Home  /  Resource Library  /  Immune recovery in patients with mantle cell lymphoma receiving long-term ibrutinib and venetoclax combination therapy

Immune recovery in patients with mantle cell lymphoma receiving long-term ibrutinib and venetoclax combination therapy

Study examined immune recovery in patients with MCL treated with ibrutinib combined with venetoclax.